English
简体中文
Total: £ 56.28
Published Date: 2024-04-08 | Pages: 86 | Tables: 179 | Pharma & Healthcare
Bruton's Tyrosine Kinase Inhibitors (BTKi), Bruton's TKI or BTKI, Ibrutinib, has shown great promise for B cell cancers with the unfortunate side effect of increased incidence of atrial fibrillation. Bruton's tyrosine kinase (BTK) inhibitors work by binding to the BTK protein. BTK inhibitors block this protein's activity by the BCR-induced BTK activation and its downstream signalling. BTK inhibitors block the activity that leads to growth of the B-cells and this causes cell death of the malignant B-cells.
The global Bruton's Tyrosine Kinase (BTKi) Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bruton's Tyrosine Kinase (BTKi) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bruton's Tyrosine Kinase (BTKi) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bruton's Tyrosine Kinase (BTKi) Inhibitors include Johnson & Johnson, AbbVie, AstraZeneca, BeiGene, InnoCare and Ono Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bruton's Tyrosine Kinase (BTKi) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bruton's Tyrosine Kinase (BTKi) Inhibitors.
Report Scope
The Bruton's Tyrosine Kinase (BTKi) Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bruton's Tyrosine Kinase (BTKi) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bruton's Tyrosine Kinase (BTKi) Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
AbbVie
AstraZeneca
BeiGene
InnoCare
Ono Pharmaceutical
Segment by Type
1st Line Treatment
2nd Line Treatment
3rd Line and Above Treatment
Segment by Application
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Mantle Cell Lymphoma
Marginal Zone Lymphoma
Small Lymphocytic Lymphoma
Waldenstrom Macroglobulinemia
B Cell Malignancies
Chronic Graft-Versus-Host Disease
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bruton's Tyrosine Kinase (BTKi) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bruton's Tyrosine Kinase (BTKi) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Overview
1.1 Product Overview and Scope of Bruton's Tyrosine Kinase (BTKi) Inhibitors
1.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Segment by Type
1.2.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Value Comparison by Type (2024-2030)
1.2.2 1st Line Treatment
1.2.3 2nd Line Treatment
1.2.4 3rd Line and Above Treatment
1.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Segment by Application
1.3.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Value by Application: (2024-2030)
1.3.2 Chronic Lymphocytic Leukemia
1.3.3 Follicular Lymphoma
1.3.4 Mantle Cell Lymphoma
1.3.5 Marginal Zone Lymphoma
1.3.6 Small Lymphocytic Lymphoma
1.3.7 Waldenstrom Macroglobulinemia
1.3.8 B Cell Malignancies
1.3.9 Chronic Graft-Versus-Host Disease
1.3.10 Others
1.4 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue 2019-2030
1.4.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales 2019-2030
1.4.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Competition by Manufacturers
2.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price by Manufacturers (2019-2024)
2.4 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bruton's Tyrosine Kinase (BTKi) Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bruton's Tyrosine Kinase (BTKi) Inhibitors, Product Type & Application
2.7 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Competitive Situation and Trends
2.7.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bruton's Tyrosine Kinase (BTKi) Inhibitors Players Market Share by Revenue
2.7.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Retrospective Market Scenario by Region
3.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region: 2019-2030
3.2.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region: 2019-2024
3.2.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region: 2025-2030
3.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Region: 2019-2030
3.3.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Region: 2019-2024
3.3.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Region: 2025-2030
3.4 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Facts & Figures by Country
3.4.1 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2019-2030)
3.4.3 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Facts & Figures by Country
3.5.1 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2019-2030)
3.5.3 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2019-2030)
3.6.3 Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2019-2030)
3.7.3 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2019-2030)
4.1.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2019-2024)
4.1.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2025-2030)
4.1.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Type (2019-2030)
4.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Type (2019-2030)
4.2.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Type (2019-2024)
4.2.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Type (2025-2030)
4.2.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Type (2019-2030)
4.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2019-2030)
5.1.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2019-2024)
5.1.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2025-2030)
5.1.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Application (2019-2030)
5.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Application (2019-2030)
5.2.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Application (2019-2024)
5.2.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Application (2025-2030)
5.2.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Application (2019-2030)
5.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 BeiGene
6.4.1 BeiGene Corporation Information
6.4.2 BeiGene Description and Business Overview
6.4.3 BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Portfolio
6.4.5 BeiGene Recent Developments/Updates
6.5 InnoCare
6.5.1 InnoCare Corporation Information
6.5.2 InnoCare Description and Business Overview
6.5.3 InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Portfolio
6.5.5 InnoCare Recent Developments/Updates
6.6 Ono Pharmaceutical
6.6.1 Ono Pharmaceutical Corporation Information
6.6.2 Ono Pharmaceutical Description and Business Overview
6.6.3 Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Portfolio
6.6.5 Ono Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Industry Chain Analysis
7.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Mode & Process
7.4 Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales and Marketing
7.4.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Channels
7.4.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Distributors
7.5 Bruton's Tyrosine Kinase (BTKi) Inhibitors Customers
8 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Dynamics
8.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Industry Trends
8.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Drivers
8.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Challenges
8.4 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bruton's Tyrosine Kinase (BTKi) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bruton's Tyrosine Kinase (BTKi) Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bruton's Tyrosine Kinase (BTKi) Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Bruton's Tyrosine Kinase (BTKi) Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bruton's Tyrosine Kinase (BTKi) Inhibitors as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2019-2024) & (K Units)
Table 18. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Region (2019-2024)
Table 19. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2025-2030) & (K Units)
Table 20. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Region (2025-2030)
Table 21. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Region (2019-2024)
Table 23. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Region (2025-2030)
Table 25. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2019-2024) & (K Units)
Table 27. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2025-2030) & (K Units)
Table 28. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2019-2024) & (K Units)
Table 32. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2025-2030) & (K Units)
Table 33. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units) by Type (2019-2024)
Table 51. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units) by Type (2025-2030)
Table 52. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Type (2019-2024)
Table 53. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Type (2025-2030)
Table 54. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Type (2019-2024)
Table 57. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Type (2025-2030)
Table 58. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price (US$/Unit) by Type (2019-2024)
Table 59. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price (US$/Unit) by Type (2025-2030)
Table 60. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units) by Application (2019-2024)
Table 61. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units) by Application (2025-2030)
Table 62. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Application (2019-2024)
Table 63. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Application (2025-2030)
Table 64. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Application (2019-2024)
Table 67. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Application (2025-2030)
Table 68. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price (US$/Unit) by Application (2019-2024)
Table 69. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price (US$/Unit) by Application (2025-2030)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 79. AbbVie Recent Developments/Updates
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. BeiGene Corporation Information
Table 86. BeiGene Description and Business Overview
Table 87. BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 89. BeiGene Recent Developments/Updates
Table 90. InnoCare Corporation Information
Table 91. InnoCare Description and Business Overview
Table 92. InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 94. InnoCare Recent Developments/Updates
Table 95. Ono Pharmaceutical Corporation Information
Table 96. Ono Pharmaceutical Description and Business Overview
Table 97. Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 99. Ono Pharmaceutical Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Bruton's Tyrosine Kinase (BTKi) Inhibitors Distributors List
Table 103. Bruton's Tyrosine Kinase (BTKi) Inhibitors Customers List
Table 104. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Trends
Table 105. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Drivers
Table 106. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Challenges
Table 107. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bruton's Tyrosine Kinase (BTKi) Inhibitors
Figure 2. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Share by Type in 2023 & 2030
Figure 4. 1st Line Treatment Product Picture
Figure 5. 2nd Line Treatment Product Picture
Figure 6. 3rd Line and Above Treatment Product Picture
Figure 7. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Share by Application in 2023 & 2030
Figure 9. Chronic Lymphocytic Leukemia
Figure 10. Follicular Lymphoma
Figure 11. Mantle Cell Lymphoma
Figure 12. Marginal Zone Lymphoma
Figure 13. Small Lymphocytic Lymphoma
Figure 14. Waldenstrom Macroglobulinemia
Figure 15. B Cell Malignancies
Figure 16. Chronic Graft-Versus-Host Disease
Figure 17. Others
Figure 18. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size (2019-2030) & (US$ Million)
Figure 20. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (2019-2030) & (K Units)
Figure 21. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Average Price (US$/Unit) & (2019-2030)
Figure 22. Bruton's Tyrosine Kinase (BTKi) Inhibitors Report Years Considered
Figure 23. Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Share by Manufacturers in 2023
Figure 24. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Share by Manufacturers in 2023
Figure 25. The Global 5 and 10 Largest Bruton's Tyrosine Kinase (BTKi) Inhibitors Players: Market Share by Revenue in 2023
Figure 26. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 27. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 28. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Country (2019-2030)
Figure 29. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Country (2019-2030)
Figure 30. United States Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Canada Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Country (2019-2030)
Figure 33. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Country (2019-2030)
Figure 34. Germany Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. France Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. U.K. Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Italy Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Russia Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Region (2019-2030)
Figure 40. Asia Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Region (2019-2030)
Figure 41. China Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Japan Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. South Korea Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. India Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Australia Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. China Taiwan Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Country (2019-2030)
Figure 49. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Bruton's Tyrosine Kinase (BTKi) Inhibitors by Type (2019-2030)
Figure 59. Global Revenue Market Share of Bruton's Tyrosine Kinase (BTKi) Inhibitors by Type (2019-2030)
Figure 60. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price (US$/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Bruton's Tyrosine Kinase (BTKi) Inhibitors by Application (2019-2030)
Figure 62. Global Revenue Market Share of Bruton's Tyrosine Kinase (BTKi) Inhibitors by Application (2019-2030)
Figure 63. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price (US$/Unit) by Application (2019-2030)
Figure 64. Bruton's Tyrosine Kinase (BTKi) Inhibitors Value Chain
Figure 65. Bruton's Tyrosine Kinase (BTKi) Inhibitors Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
